Crossmark

New perspectives for targeting therapy in ALK-positive human cancers

Crossref DOI link: https://doi.org/10.1038/s41388-023-02712-8

Published Online: 2023-05-06

Published Print: 2023-06-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Simin

Li, Jian

Xia, Qingxin

Liu, Kangdong https://orcid.org/0000-0002-4425-5625
Dong, Zigang https://orcid.org/0000-0002-4174-4028
License Information

Text and Data Mining valid from 2023-05-06

Version of Record valid from 2023-05-06
More Information

Article History

Received: 14 March 2022

Accepted: 27 April 2023

First Online: 6 May 2023

Competing interests

: The authors declare no competing interests.